Figure 1From: Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population Intension to treat analysis for patients with genotype 1 and genotype 2/3. RVR, EVR, ETR, and SVR rates were not statistically different between the two PEG-IFN groups in patients with genotype 1 (A) and genotype 2/3 (B).Back to article page